About Life Technologies
Life Technologies is a company based in Carlsbad (United States) founded in 1983 was acquired by Thermo Fisher Scientific in April 2013. Life Technologies has completed 9 acquisitions, including AcroMetrix, BACBV and Biotrove. Life Technologies offers products and services including Antibodies, Cell Culture Media, TaqMan Real-Time PCR Assays, and Chromatography Columns. Life Technologies operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Carlsbad, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ethos Technologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$4.81 M (USD), Grant
Apr 22, 2009
-
Investors
Thermo Fisher Scientific
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
AcroMetrix
& 8 more
-
Acquired by
Thermo Fisher Scientific
(Apr 15, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Life Technologies
Life Technologies is a publicly listed company on the NASDAQ with ticker symbol LIFE in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Life Technologies
Life Technologies offers a comprehensive portfolio of products and services, including Antibodies, Cell Culture Media, TaqMan Real-Time PCR Assays, and Chromatography Columns.
Used for immunological research and diagnostics in labs
Supports growth of cells for bioprocessing applications
Enables DNA analysis for genetic and diagnostic studies
Facilitates separation of chemicals in research settings
People of Life Technologies
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
169 people
Sales and Marketing
138 people
Human Resources and Administration
102 people
Product Management Team
68 people
Finance and Accounting
67 people
Senior Team
59 people
Operations Team
52 people
Unlock access to complete
Funding Insights of Life Technologies
Investors in Life Technologies
Life Technologies has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, NEA and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked | |
|
Electron microscopy services and microanalysis instruments are provided.
|
Locked | Locked | Locked |
Investor details for Life Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Life Technologies
Life Technologies has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include AcroMetrix, BACBV and Biotrove.
Investment portfolio details for Life Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Next-generation sequencing is enabled by semiconductor technology for DNA analysis.
|
Locked | Locked | 2007 | Locked | |
|
Cancer genomics data is collected and analyzed for drug development.
|
Locked | Locked | 2006 | Locked | |
|
Genomic data and tools are offered for oncology biomarker discoveries.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Life Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Life Technologies
Detailed financials for Life Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Life Technologies Comparisons
Peer comparison for Life Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Life Technologies
Life Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of Life Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Life Technologies
Complete news archive for Life Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Life Technologies
Life Technologies was founded in 1983.
Life Technologies is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Life Technologies Corporation was a biotech company founded through a merger of Invitrogen Corporation and Applied Biosystems. The joint sales of the combined companies were about 3.5 billion; they had about 9,500 employees, and owned more than 3,600 licenses and patents. Thermo Fisher Scientific Corporation acquired the company in 2014 and used the Life Technologies brand name for a family of biotechnology products and services from Feb 2014 to July 2015. Thermo Fisher retired the Life Technologies brand name and logos in late July 2015. Life Technologies provided essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactured and marketed a breadth of offerings used in applications of the life sciences discovery, development, and production process. The offerings ranged from catalog and custom products to technology licensing, research services, large-scale production, and life science technical expertise and support.
Life Technologies's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Life Technologies offers Antibodies, Cell Culture Media, TaqMan Real-Time PCR Assays, and Chromatography Columns.
Yes, Life Technologies is publicly traded on NASDAQ under the ticker symbol LIFE.
Life Technologies has made 9 acquisitions, including AcroMetrix, BACBV, and Biotrove.
Life Technologies has 3 investors. Key investors include Thermo Fisher Scientific, NEA, and Military Health.
The ticker symbol of Life Technologies is LIFE on NASDAQ.